Digg icon reddit icon Stumbleupon icon
Print Email     Print Edition Stories

Thursday, September 15, 2011

GE, VC firms launch innovation challenge to fight cancer

By Michelle Lang

GE and venture capital firms Kleiner Perkins Caufield & Byers, Venrock, Mohr Davidow and MPM Capital have launched a $100 million healthymagination open innovation challenge aimed at funding promising initiatives that may improve breast cancer diagnostics.

The initiative is expected to support progress in understanding the more aggressive triple negative cancer, improving early detection and enabling better treatment for cancer patients, according to a news release today.

Winners of the innovation challenge, to be announced in early 2012, will receive $100,000 seed grants. Representatives from GE, Kleiner Perkins Caufield & Byers, Venrock, Mohr Davidow and MPM Capital will initially evaluate the innovation challenge applications, and a separate, independent panels of judges will choose the winners.

In its news release, GE also said that it would spend $1 billion in the next five years to grow its cancer detection and treatment research and development, with its initial focus on breast cancer.
 

Comments

If you are commenting using a Facebook account, your profile information may be displayed with your comment depending on your privacy settings. By leaving the 'Post to Facebook' box selected, your comment will be published to your Facebook profile in addition to the space below.

Digg icon reddit icon Stumbleupon icon
Contact Editor Latest News

Tech Pulse Poll

Should RI officials have approved the $75M loan to 38 Studios?



View Results

Stay Informed
Check which newsletter you'd like to receive.
TechFlash (Daily)
BioFlash (Daily)
GreenFlash (Weekly)
Startup Report (Weekly)
Breaking news, MHT events, local announcements
RSS feeds
Your email:

Affiliate publications: ACBJ.com, Boston Business Journal, Bizjournals.com, Portfolio.com, Wired.com

Web Site Developed by Neptune Web, Inc.

Use of and/or registration on any portion of this site constitutes acceptance of our User Agreement and Privacy Policy. About our ads.